You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen-Resistant Prostatic Neoplasms

Showing 1 - 25 of 8,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 23, 2023

    Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

    Recruiting
    • Prostate Cancer
    • Brasília, Distrito Federal, Brazil
    • +4 more
    Dec 22, 2022

    Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

    Recruiting
    • Castration-resistant Prostate Cancer
    • Homologous Recombination Deficiency
    • Testosterone Enanthate 100 MG/ML Injectable Solution
    • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
    • Sydney, New South Wales, Australia
      Kinghorn Cancer Centre, St. Vincent's Hospital
    Dec 16, 2022

    Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

    Not yet recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
    Sep 22, 2023

    Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

    Not yet recruiting
    • Prostatic Neoplasm
    • (no location specified)
    Apr 27, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Biopsy
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2023

    Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +7 more
    • Biopsy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Prostate Cancer Trial in Multiple Locations (Darolutamide 600 mg twice daily, Placebo 600 mg twice daily, Androgen deprivation

    Recruiting
    • Prostate Cancer
    • Darolutamide 600 mg twice daily
    • +2 more
    • Multiple Locations, China
      Many Locations
    Aug 2, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • ONC-392
    • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
    • (no location specified)
    Dec 27, 2022

    Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

    Recruiting
    • Castrate Resistant Prostate Cancer
    • Chicago, Illinois
    • +2 more
    Jul 19, 2022

    Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • 177Lu-DOTA-rosopatamb
    • (no location specified)
    Aug 29, 2022

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

    Active, not recruiting
    Has Results
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Laboratory Biomarker Analysis
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 19, 2022

    Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

    Active, not recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Ahmedabad, India
    • +7 more
    Jan 21, 2023

    Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

    Suspended
    • Prostatic Neoplasms
    • Towson, Maryland
    • +3 more
    Nov 3, 2022

    Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 27, 2022

    Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer Trial in San Francisco, Baltimore, Boston

    Active, not recruiting
    • Castration-resistant Prostate Cancer
    • +2 more
    • San Francisco, California
    • +2 more
    Nov 16, 2021

    Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer Trial in United States (VERU-111,

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Androgen Resistant Prostatic Cancer
    • Anchorage, Alaska
    • +43 more
    Jan 3, 2023

    Prostate Cancer Trial in Detroit, New York (Cabozantinib)

    Recruiting
    • Prostate Cancer
    • Detroit, Michigan
    • +2 more
    Mar 30, 2022

    Prostate Cancer Trial in Kogarah, Liverpool, Bedford Park (PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone)

    Recruiting
    • Prostate Cancer
    • Ann Arbor, Michigan
    • +4 more
    Jan 6, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

    Terminated
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Computed Tomography
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 19, 2022